P, Y., & B, X. (2021). Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective. Dove Medical Press.
Cita Chicago Style (17a ed.)P, Yuan, y Xu B. Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective. Dove Medical Press, 2021.
Cita MLA (8a ed.)P, Yuan, y Xu B. Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective. Dove Medical Press, 2021.
Precaución: Estas citas no son 100% exactas.